[Expression of Concern] AHIF promotes glioblastoma progression and radioresistance via exosomes.

IF 4.9 3区医学 Q1 ONCOLOGY

International journal of oncology Pub Date : 2026-06-01 Epub Date: 2026-04-17 DOI:10.3892/ijo.2026.5883

Xuejun Dai, Keman Liao, Zhijun Zhuang, Binghong Chen, Zhiyi Zhou, Sunhai Zhou, Guoshi Lin, Feifei Zhang, Yingying Lin, Yifeng Miao, Zhiqiang Li, Renhua Huang, Yongming Qiu, Ruisheng Lin

{"title":"[Expression of Concern] AHIF promotes glioblastoma progression and radioresistance via exosomes.","authors":"Xuejun Dai, Keman Liao, Zhijun Zhuang, Binghong Chen, Zhiyi Zhou, Sunhai Zhou, Guoshi Lin, Feifei Zhang, Yingying Lin, Yifeng Miao, Zhiqiang Li, Renhua Huang, Yongming Qiu, Ruisheng Lin","doi":"10.3892/ijo.2026.5883","DOIUrl":null,"url":null,"abstract":"<p><p>Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, in Fig. 2E on p. 264, the Transwell invasion assay results shown in the \"T98G‑AHIF KD\" data panel appeared to potentially contain an overlapping section with the \"U251‑AHIF OE\" data panel in Fig. 3E. The authors were contacted by the Editorial Office to offer an explanation for this apparent anomaly in the presentation of the data in this paper; however, up to this time, no response from them has been forthcoming. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [International Journal of Oncology 54: 261‑270, 2019; DOI: 10.3892/ijo.2018.4621].</p>","PeriodicalId":14175,"journal":{"name":"International journal of oncology","volume":"68 6","pages":""},"PeriodicalIF":4.9000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13124142/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3892/ijo.2026.5883","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/17 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Following the publication of the above paper, it was drawn to the Editor's attention by a concerned reader that, in Fig. 2E on p. 264, the Transwell invasion assay results shown in the "T98G‑AHIF KD" data panel appeared to potentially contain an overlapping section with the "U251‑AHIF OE" data panel in Fig. 3E. The authors were contacted by the Editorial Office to offer an explanation for this apparent anomaly in the presentation of the data in this paper; however, up to this time, no response from them has been forthcoming. Owing to the fact that the Editorial Office has been made aware of potential issues surrounding the scientific integrity of this paper, we are issuing an Expression of Concern to notify readers of this potential problem while the Editorial Office continues to investigate this matter further. [International Journal of Oncology 54: 261‑270, 2019; DOI: 10.3892/ijo.2018.4621].

查看原文本刊更多论文

[关注表达]AHIF通过外泌体促进胶质母细胞瘤的进展和放射耐药。

在上述论文发表后，一位关心的读者引起了编辑的注意，在第264页的图2E中，“T98G - AHIF KD”数据面板中显示的Transwell侵袭试验结果似乎可能与图3E中的“U251 - AHIF OE”数据面板中包含重叠部分。编辑部联系了作者，要求他们对这篇论文中数据呈现的明显异常作出解释；然而，到目前为止，他们还没有任何回应。由于编辑部已经意识到围绕本文科学完整性的潜在问题，在编辑部继续进一步调查此事的同时，我们发出一份关注表达，通知读者这一潜在问题。国际肿瘤学杂志54:261 - 270,2019；DOI: 10.3892 / ijo.2018.4621]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International journal of oncology 医学-肿瘤学

CiteScore

9.60

自引率

0.00%

发文量

157

审稿时长

2.1 months

期刊介绍： The main aim of Spandidos Publications is to facilitate scientific communication in a clear, concise and objective manner, while striving to provide prompt publication of original works of high quality. The journals largely concentrate on molecular and experimental medicine, oncology, clinical and experimental cancer treatment and biomedical research. All journals published by Spandidos Publications Ltd. maintain the highest standards of quality, and the members of their Editorial Boards are world-renowned scientists.